» Articles » PMID: 38365752

Genome-wide Association Study and Polygenic Risk Scores of Retinal Thickness Across the Cognitive Continuum: Data from the NORFACE Cohort

Abstract

Background: Several studies have reported a relationship between retinal thickness and dementia. Therefore, optical coherence tomography (OCT) has been proposed as an early diagnosis method for Alzheimer's disease (AD). In this study, we performed a genome-wide association study (GWAS) aimed at identifying genes associated with retinal nerve fiber layer (RNFL) and ganglion cell inner plexiform layer (GCIPL) thickness assessed by OCT and exploring the relationships between the spectrum of cognitive decline (including AD and non-AD cases) and retinal thickness.

Methods: RNFL and GCIPL thickness at the macula were determined using two different OCT devices (Triton and Maestro). These determinations were tested for association with common single nucleotide polymorphism (SNPs) using adjusted linear regression models and combined using meta-analysis methods. Polygenic risk scores (PRSs) for retinal thickness and AD were generated.

Results: Several genetic loci affecting retinal thickness were identified across the genome in accordance with previous reports. The genetic overlap between retinal thickness and dementia, however, was weak and limited to the GCIPL layer; only those observable with all-type dementia cases were considered.

Conclusions: Our study does not support the existence of a genetic link between dementia and retinal thickness.

Citing Articles

Cell-type specific epigenetic clocks to quantify biological age at cell-type resolution.

Tong H, Guo X, Jacques M, Luo Q, Eynon N, Teschendorff A Aging (Albany NY). 2025; 16(22):13452-13504.

PMID: 39760516 PMC: 11723652. DOI: 10.18632/aging.206184.

References
1.
Rodriguez-Gomez O, Sanabria A, Perez-Cordon A, Sanchez-Ruiz D, Abdelnour C, Valero S . FACEHBI: A Prospective Study of Risk Factors, Biomarkers and Cognition in a Cohort of Individuals with Subjective Cognitive Decline. Study Rationale and Research Protocols. J Prev Alzheimers Dis. 2017; 4(2):100-108. DOI: 10.14283/jpad.2016.122. View

2.
Bokinni Y, Shah N, Maguire O, Laidlaw D . Performance of a computerised visual acuity measurement device in subjects with age-related macular degeneration: comparison with gold standard ETDRS chart measurements. Eye (Lond). 2015; 29(8):1085-91. PMC: 4541361. DOI: 10.1038/eye.2015.94. View

3.
Sanchez D, Castilla-Marti M, Rodriguez-Gomez O, Valero S, Piferrer A, Martinez G . Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer's disease. Sci Rep. 2018; 8(1):16345. PMC: 6218495. DOI: 10.1038/s41598-018-34577-3. View

4.
Sadun A, Bassi C . Optic nerve damage in Alzheimer's disease. Ophthalmology. 1990; 97(1):9-17. DOI: 10.1016/s0161-6420(90)32621-0. View

5.
Chang C, Chow C, Tellier L, Vattikuti S, Purcell S, Lee J . Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015; 4:7. PMC: 4342193. DOI: 10.1186/s13742-015-0047-8. View